There is something fundamentally reassuring when you see the big players hunting around for pre-clinical M&A targets...USD $1B upfront and a further USD$750M for performance milestones. Conclusion: TLX undervalued given established revenue and a pipeline that has near-term catalysts. Enjoy.
.https://www.novartis.com/news/media-releases/novartis-enters-agreement-acquire-mariana-oncology-strengthening-radioligand-therapy-pipeline
- Forums
- ASX - By Stock
- TLX
- 'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO)
'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO), page-28
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.45 |
Change
-0.510(2.84%) |
Mkt cap ! $5.830B |
Open | High | Low | Value | Volume |
$17.90 | $18.13 | $17.25 | $23.78M | 1.358M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 4746 | $17.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.46 | 979 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 287 | 17.400 |
1 | 1000 | 17.390 |
1 | 1000 | 17.300 |
1 | 92 | 17.270 |
1 | 173 | 17.260 |
Price($) | Vol. | No. |
---|---|---|
17.550 | 2835 | 2 |
17.620 | 2500 | 1 |
17.650 | 1690 | 2 |
17.690 | 755 | 1 |
17.720 | 776 | 1 |
Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
Last
$17.53 |
  |
Change
-0.510 ( 2.11 %) |
|||
Open | High | Low | Volume | ||
$17.99 | $18.12 | $17.26 | 233497 | ||
Last updated 15.59pm 07/06/2024 ? |
Featured News
TLX (ASX) Chart |